Ohio doctor arrested after ‘secretly giving abortion medication to girlfriend and causing a miscarriage’

An Ohio doctor is facing criminal charges after authorities say he secretly and forcibly administered abortion medication to ...
PharmiWeb

FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma

Lunsumio VELO reduces administration time from 2-4 hours to approximately one minute –– Availability of Lunsumio VELO allows ...

Ohio doctor accused of forcing abortion pill, inducing miscarriage on pregnant girlfriend

TOLEDO, Ohio ( WCMH) — A doctor who worked at a northwestern Ohio hospital has been arrested after being accused of secretly and forcefully administering abortion medication to a woman he reportedly ...

ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Breakthrough Therapy Designation in the US as post-neoadjuvant therapy for patients with HER2-positive early breast cancer

AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD) in the US for adult patients with HER2-positive early breast cancer ...